The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma

Annals of Surgical Oncology

Volumn 17, Issue 2, 2010, Pages 392-400

  Meyer Rochow, Goswin Y ^a,b   Schembri, Geoff P ^b   Benn, Diana E ^a   Sywak, Mark S ^b   Delbridge, Leigh W ^b   Robinson, Bruce G ^a,b   Roach, Paul J ^b   Sidhu, Stan B ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; CATECHOLAMINE;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; RADIODIAGNOSIS; RECURRENT CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHEOCHROMOCYTOMA; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77149152499     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0850-5     Document Type: Article

References (40)

1. RK Whalen AF Althausen GH Daniels 1992 Extra-adrenal pheochromocytoma J Urol 147 1 10 1:STN:280:DyaK387gs1emtw%3D%3D 1729490
2. HP Neumann B Bausch SR McWhinney, et al. 2002 Germ-line mutations in nonsyndromic pheochromocytoma N Engl J Med 346 1459 1466 10.1056/NEJMoa020152 1:CAS:528:DC%2BD38XjsVynsLc%3D 12000816 (Pubitemid 34755714)
3. L Amar A Servais AP Gimenez-Roqueplo, et al. 2005 Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma J Clin Endocrinol Metab 90 2110 2116 10.1210/jc.2004-1398 1:CAS:528:DC%2BD2MXjsFWjtLk%3D 15644401 (Pubitemid 40586247)
4. MM Walther HR Keiser WM Linehan 1999 Pheochromocytoma: evaluation, diagnosis, and treatment World J Urol 17 35 39 10.1007/s003450050102 1:STN:280:DyaK1M7psFyrsQ%3D%3D 10096149
5. JW Lenders G Eisenhofer M Mannelli K Pacak 2005 Pheochromocytoma Lancet 366 665 675 10.1016/S0140-6736(05)67139-5 16112304 (Pubitemid 41176020)
6. HJ Timmers A Kozupa G Eisenhofer, et al. 2007 Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas J Clin Endocrinol Metab 92 779 786 10.1210/jc.2006-2315 1:CAS:528:DC%2BD2sXjtlGntb4%3D 17200167 (Pubitemid 46465640)
7. FM Brouwers G Eisenhofer JJ Tao, et al. 2006 High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing J Clin Endocrinol Metab 91 4505 4509 10.1210/jc.2006-0423 1:CAS:528:DC%2BD28Xht1WhurjN 16912137 (Pubitemid 44833431)
8. DY Greenblatt Y Shenker H Chen 2008 The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma Ann Surg Oncol 15 900 905 10.1245/s10434-007-9776-y 18193324
9. J Miskulin BL Shulkin GM Doherty, et al. 2003 Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma? Surgery. 134 918 922 10.1016/S0039-6060(03) 00416-1 14668723 discussion 922-3 (Pubitemid 38010736)
10. 123I- metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal pheochromocytomas: CT and MRI correlation Clin Endocrinol (Oxf) 69 181 188 10.1111/j.1365-2265.2008.03256.x (Pubitemid 352009037)
11. R Mihai F Gleeson D Roskell, et al. 2008 Routine preoperative (123)I-MIBG scintigraphy for patients with pheochromocytoma is not necessary Langenbecks Arch Surg 393 725 727 10.1007/s00423-008-0387-2 18663465
12. 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial J Nucl Med 50 1448 1454 10.2967/jnumed.108. 058701 1:CAS:528:DC%2BD1MXhtFOrtbrL 19690028
13. K Rozovsky BZ Koplewitz Y Krausz, et al. 2008 Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma AJR Am J Roentgenol 190 1085 1090 10.2214/AJR.07.2107 18356459 (Pubitemid 351571524)
14. K Strobel C Burger P Schneider, et al. 2007 MIBG-SPECT/CT-angiography with 3-D reconstruction of an extra-adrenal pheochromocytoma with dissection of an aortic aneurysm Eur J Nucl Med Mol Imaging 34 150 10.1007/s00259-006-0240-1 17033846 (Pubitemid 44885567)
15. S Maurea A Cuocolo JC Reynolds, et al. 1996 Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison Q J Nucl Med 40 365 371 1:STN:280:DyaK2s3gt12htw%3D%3D 9050342
16. I Ilias K Pacak 2004 Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma J Clin Endocrinol Metab 89 479 491 10.1210/jc.2003-031091 1:CAS:528:DC%2BD2cXhsFKqu7Y%3D 14764749 (Pubitemid 38269845)
17. 123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison J Nucl Med 28 973 978 1:STN:280: DyaL2s3isFajsQ%3D%3D 3585505
18. 131I] iodobenzylguanidine J Nucl Med 21 349 353 1:CAS:528:DyaL3cXkt1WltLY%3D 7381563
19. CA Hoefnagel PA Voute J de Kraker HR Marcuse 1987 Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine J Nucl Med 28 308 314 1:STN:280:DyaL2s7ktVaqtg%3D%3D 3102701
20. 131I-metaiodobenzylguanidine Lancet 2 165 10.1016/S0140-6736(84)91081-X 1:STN:280:DyaL2c3ksV2jsw%3D%3D 6146062
21. Evans AE, D'Angio GJ, Knudson AG, Seeger RC (ed). Advances in neuroblastomas research. New York: Alan R. Liss; 1988.
22. JD Lumbroso F Guermazi O Hartmann, et al. 1988 Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans Prog Clin Biol Res 271 689 705 1:STN:280:DyaL1czgtl2htA%3D%3D 3261424
23. Roach PJ. Combining structure and function: the future of medical imaging. Int Med J. 2005:577-9.
24. 111In- DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours Radiol Med 113 1056 1067 10.1007/s11547-008-0319-9 1:STN:280: DC%2BD1cjosFCjsw%3D%3D 18797822
25. G Eisenhofer G Siegert J Kotzerke, et al. 2008 Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas Horm Metab Res 40 329 337 10.1055/s-2008-1073156 1:CAS:528:DC%2BD1cXotFyrsbk%3D 18491252 (Pubitemid 351859444)
26. PE Hickman M Leong J Chang, et al. 2009 Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of pheochromocytoma Pathology 41 173 177 10.1080/00313020802579284 1:CAS:528:DC%2BD1MXotlKqtQ%3D%3D 19152190
27. Yu R. Ordering pattern and performance of biochemical tests for diagnosing pheochromocytoma from 2000 to 2008. Endocr Pract. 2009:1-27.
28. Manger WM, Gifford RD (eds). Clinical and experimental pheochromocytoma. Cambridge: Blackwell Science; 1996.
29. Y Alderazi MW Yeh BG Robinson, et al. 2005 Pheochromocytoma: current concepts Med J Aust 183 201 204 16097921
30. WM Manger 2006 An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges Ann N Y Acad Sci 1073 1 20 10.1196/annals.1353.001 1:CAS:528:DC%2BD28XhtFSgsrrI 17102067 (Pubitemid 44911993)
31. M Abe Y Orita Y Nakashima M Nakamura 1984 Hypertensive crisis induced by metoclopramide in patient with pheochromocytoma Angiology 35 122 128 10.1177/000331978403500209 1:STN:280:DyaL2c7is1Wktw%3D%3D 6696287
32. AM Lawrence 1967 Glucagon provocative test for pheochromocytoma Ann Intern Med 66 1091 1096 1:CAS:528:DyaF2sXksVantLc%3D 6027944
33. B Eriksson M Bergstrom A Sundin, et al. 2002 The role of PET in localization of neuroendocrine and adrenocortical tumors Ann N Y Acad Sci 970 159 169 10.1111/j.1749-6632.2002.tb04422.x 1:CAS:528:DC%2BD38XovFalurg%3D 12381551
34. V Rufini ML Calcagni RP Baum 2006 Imaging of neuroendocrine tumors Semin Nucl Med 36 228 247 10.1053/j.semnuclmed.2006.03.007 16762613 (Pubitemid 43817847)
35. I Ilias K Pacak 2004 Anatomical and functional imaging of metastatic pheochromocytoma Ann N Y Acad Sci 1018 495 504 10.1196/annals.1296.061 1:CAS:528:DC%2BD2cXms12nu70%3D 15240407 (Pubitemid 38951445)
36. MD Gross PG Gauger M Djekidel D Rubello 2009 The role of PET in the surgical approach to adrenal disease Oncol Rep 35 11 1137 1145 1:STN:280:DC%2BD1MnptlSiug%3D%3D
37. T Nakatani T Hayama J Uchida, et al. 2002 Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging Oncol Rep 9 1225 1227 12375024
38. B Shapiro MD Gross 1987 Radiochemistry, biochemistry, and kinetics of 131I-metaiodobenzylguanidine (MIBG) and 123I-MIBG: clinical implications of the use of 123I-MIBG Med Pediatr Oncol 15 170 177 10.1002/mpo.2950150406 1:STN:280:DyaL1c%2FhtlKhsw%3D%3D 3309602
39. K Ikekubo M Hino H Ootsuka, et al. 1994 Detection of neural crest tumors by 123I-MIBG scintigraphy Kaku Igaku 31 1357 1364 1:STN:280:DyaK2M7jvFGitA%3D%3D 7837704
40. GS Anderson S Fish K Nakhoda, et al. 2003 Comparison of I-123 and I-131 for whole-body imaging after stimulation by recombinant human thyrotropin: a preliminary report Clin Nucl Med 28 93 96 10.1097/00003072-200302000-00001 12544124 (Pubitemid 38281999)